Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 1—January 2024
Research Letter

Frequency of Children Diagnosed with Perinatal Hepatitis C, United States, 2018–2020

Suzanne M. NewtonComments to Author , Kate R. Woodworth, Daniel Chang, Lindsey Sizemore, Heather Wingate, Leah Pinckney, Anthony Osinski, Lauren Orkis, Bethany D. Reynolds, Cynthia Carpentieri, Umme-Aiman Halai, Caleb Lyu, Nicole Longcore, Nadia Thomas, Aprielle Wills, Amanda Akosa, Emily O’Malley Olsen, Lakshmi Panagiotakopoulos, Nicola D. Thompson, Suzanne M. Gilboa, and Van T. Tong
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.M. Newton, K.R. Woodworth, E.O. Olsen, L. Panagiotakopoulos, N.D. Thompson, S.M. Gilboa, V.T. Tong); Eagle Global Scientific, LLC, San Antonio, Texas, USA (D. Chang, A. Akosa); Tennessee Department of Health, Nashville, Tennessee, USA (L. Sizemore, H. Wingate); Massachusetts Department of Public Health, Boston, Massachusetts, USA (L. Pinckney, A. Osinski); Pennsylvania Department of Health, Pittsburgh, Pennsylvania, USA (L. Orkis, B.D. Reynolds); Chickasaw Nation Industries, Norman, Oklahoma, USA (C. Carpentieri); Los Angeles County Department of Health, Los Angeles, California, USA (U-A. Halai, C. Lyu); New York State Department of Health, Albany, New York, USA (N. Longcore, N. Thomas); New York City Department of Health and Mental Hygiene, New York City, New York (A. Wills)

Main Article

Figure

Observed and expected HCV infections among children with perinatal hepatitis C exposure in 7 US jurisdictions, 2018–2020. *Appropriate testing is considered test conducted at ≥2 months for HCV RNA or ≥18 months for HCV antibody. †May include children who tested negative for HCV, children whose tests were not reported to the health department, or children tested at an inappropriate age (<2 months for HCV RNA; <18 months for HCV antibody). HCV, Hepatitis C virus.

Figure. Observed and expected HCV infections among children with perinatal hepatitis C exposure in 7 US jurisdictions, 2018–2020. *Appropriate testing is considered test conducted at ≥2 months for HCV RNA or ≥18 months for HCV antibody. †May include children who tested negative for HCV, children whose tests were not reported to the health department, or children tested at an inappropriate age (<2 months for HCV RNA; <18 months for HCV antibody). HCV, Hepatitis C virus.

Main Article

Page created: November 19, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external